Comparing Psychedelic-Assisted Therapy with Traditional Therapy for Mental Illnesses – Part 2 Read More > December 11, 2024
Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study Read More > August 9, 2021
Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes Read More > March 23, 2021
Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review Read More > March 7, 2021
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder Read More > February 18, 2021
What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review Read More > February 11, 2021
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine Read More > January 25, 2021
Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders Read More > January 20, 2021
